TOM, Nikola, O. TOM, Jitka MALČÍKOVÁ, Šárka PAVLOVÁ, Blanka KUBEŠOVÁ, T. RAUSCH, M. KOLARIK, V. BENES, Vojtěch BYSTRÝ and Šárka POSPÍŠILOVÁ. ToTem: a tool for variant calling pipeline optimization. BMC Bioinformatics. London: BioMed Central, 2018, vol. 19, JUN, p. 243-251. ISSN 1471-2105. Available from: https://dx.doi.org/10.1186/s12859-018-2227-x.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name ToTem: a tool for variant calling pipeline optimization
Authors TOM, Nikola (203 Czech Republic, belonging to the institution), O. TOM (203 Czech Republic), Jitka MALČÍKOVÁ (203 Czech Republic, belonging to the institution), Šárka PAVLOVÁ (203 Czech Republic, belonging to the institution), Blanka KUBEŠOVÁ (203 Czech Republic, belonging to the institution), T. RAUSCH (276 Germany), M. KOLARIK (203 Czech Republic), V. BENES (276 Germany), Vojtěch BYSTRÝ (203 Czech Republic, belonging to the institution) and Šárka POSPÍŠILOVÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition BMC Bioinformatics, London, BioMed Central, 2018, 1471-2105.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.511
RIV identification code RIV/00216224:14740/18:00101855
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1186/s12859-018-2227-x
UT WoS 000436517200004
Keywords in English Variant calling; Benchmarking; Next generation sequencing; Parameter optimization
Tags 14110212, CF GEN, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 13/3/2019 17:22.
Abstract
Background: High-throughput bioinformatics analyses of next generation sequencing (NGS) data often require challenging pipeline optimization. The key problem is choosing appropriate tools and selecting the best parameters for optimal precision and recall. Results: Here we introduce ToTem, a tool for automated pipeline optimization. ToTem is a stand-alone web application with a comprehensive graphical user interface (GUI). ToTem is written in Java and PHP with an underlying connection to a MySQL database. Its primary role is to automatically generate, execute and benchmark different variant calling pipeline settings. Our tool allows an analysis to be started from any level of the process and with the possibility of plugging almost any tool or code. To prevent an over-fitting of pipeline parameters, ToTem ensures the reproducibility of these by using cross validation techniques that penalize the final precision, recall and F-measure. The results are interpreted as interactive graphs and tables allowing an optimal pipeline to be selected, based on the user's priorities. Using ToTem, we were able to optimize somatic variant calling from ultra-deep targeted gene sequencing (TGS) data and germline variant detection in whole genome sequencing (WGS) data. Conclusions: ToTem is a tool for automated pipeline optimization which is freely available as a web application at https://totern.software
Links
EF16_013/0001818, research and development projectName: Modernizace a podpora výzkumných aktivit národní infrastruktury pro translační medicínu EATRIS-CZ
LM2015064, research and development projectName: Český národní uzel Evropské infrastruktury pro translační medicínu (Acronym: EATRIS-ERIC-CZ)
Investor: Ministry of Education, Youth and Sports of the CR
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/0968/2017, interní kód MUName: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V (Acronym: VýDiTeHeMA V)
Investor: Masaryk University, Category A
NV15-30015A, research and development projectName: Analýza klonální heterogenity chronické lymfocytární leukemie pomoci sekvenování nové generace genu pro B-buněčný receptor. Národní studie.
NV15-31834A, research and development projectName: Vliv selekce genomických poškození na průběh chronické lymfocytární leukémie
TE02000058, research and development projectName: Centrum kompetence pro molekulární diagnostiku a personalizovanou medicínu (Acronym: MOLDIMED)
Investor: Technology Agency of the Czech Republic
692298, interní kód MUName: MEDGENET - Medical genomics and epigenomics network (Acronym: MEDGENET)
Investor: European Union, Spreading excellence and widening participation
PrintDisplayed: 23/7/2024 03:20